Metergoline

01/01/1983 - "Forty patients with hyperprolactinaemia were treated with metergoline (8 to 12 mg/day) for periods up to 5 years. "
01/01/1983 - "Treatment of hyperprolactinaemia with metergoline for periods up to 5 years: clinical and biological tolerability."
05/01/1977 - "Pregnancy following metergoline treatment in a patient with hyperprolactinaemia."
01/01/1991 - "The usage of metergoline in patients with infertility and different forms (hinds) of hyperprolactinaemia was studied for 90 days at a dose of 12 mg. It gives a possibility to stimulate ovulation in 64% of patients and gain pregnancy in 8% of patients. "
01/01/1991 - "[Use of metergoline in the treatment of infertility associated with hyperprolactinemia]."

01/01/1984 - "In a multicentric study, the effect of the antiserotoninergic agent metergoline was evaluated in the management of patients with idiopathic normoprolactinemic secondary amenorrhea (NSA). "
02/01/1986 - "Treatment of hyperprolactinemic amenorrhea with Metergoline."
01/01/1984 - "Metergoline in the management of normoprolactinemic secondary amenorrhea. "
01/01/1982 - "In patients with amenorrhea, metergoline induced the appearance of menses in 61 cases (94%), and of ovulation in 46 cases (82%). "
06/01/1981 - "[Methergoline therapy of hyperprolactinemic amenorrhea. "

05/20/1983 - "[Studies on the induction of ovulation by metergoline in women with normoprolactinemic anovulation]."
01/01/1982 - "These results indicate metergoline as a safe and effective drug in the management of hyperprolactinemic amenorrhea and anovulation. "
01/01/1982 - "Metergoline in the management of hyperprolactinemic amenorrhea and anovulation."
08/01/1983 - "59 patients affected by amenorrhea or anovulation, 37 of whom also with galactorrhea, and with hyperprolactinemia of unknown origin (idiopathic hyperprolactinemia, 24 patients) or due to a pituitary microadenoma (tumoral hyperprolactinemia, 35 patients) were treated with metergoline (4-12 mg/day) or with bromocriptine (2.5 to 10 mg/day) for 90 days. "

06/01/1991 - "The lack of effect of RTS in PRL-secreting pituitary adenomas suggests that the reported suppression of PRL by other antiserotoninergic drugs, such as metergoline, is probably due to their concomitant dopaminergic activity."
05/01/1982 - "Bromocriptine and metergoline were equally effective in the treatment of functional hyperprolactinaemia and of untreated microadenomas, while bromocriptine showed a more potent Prl-lowering effect than metergoline in patients with higher Prl levels and large prolactinomas; both drugs restored the gonadal function to a similar extent, though metergoline was effective in some cases, even in the absence of full Prl suppression. "

02/10/2022 - "Cinnamide and arylacrylamide derivatives show improved potency relative to metergoline against Gram-positive bacteria, and pyridine derivative 38 is also effective against methicillin-resistant Staphylococcus aureus (MRSA) in a murine skin infection model. "